FindTrial
Sign In

ALIMTA

DRUG14 trials

Sponsors

Eli Lilly and Company, Dana-Farber Cancer Institute, Millennium Pharmaceuticals, Inc., University of California, Davis, M.D. Anderson Cancer Center

Conditions

Breast CancerCancerCarcinoma, Non-Small-Cell LungColorectal CancerLung CancerLung NeoplasmsMalignant Pleural MesotheliomaMetastases

Phase 1

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.
CompletedNCT00034502
Eli Lilly and CompanyColorectal Cancer
Updated: 2006-07-19
ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
CompletedNCT00034463
Eli Lilly and CompanyCancer, Metastases
Updated: 2006-07-19
Abraxane and Alimta in Advanced Solid Tumors
TerminatedNCT00470548
University of California, DavisBreast Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Start: 2007-04-30End: 2014-10-31Updated: 2018-01-10

Phase 2

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
CompletedNCT00034593
Eli Lilly and CompanyUrologic Neoplasms
Updated: 2006-07-19
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
CompletedNCT00034619
Eli Lilly and CompanyColorectal Cancer
Updated: 2006-07-19
ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.
CompletedNCT00051506
Eli Lilly and CompanyLung Neoplasms
Updated: 2006-07-20
ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
CompletedNCT00051493
Eli Lilly and CompanyCarcinoma, Non-Small-Cell Lung
Start: 2002-04-30End: 2002-12-31Target: 50Updated: 2006-07-19
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
TerminatedNCT00165503
Dana-Farber Cancer InstituteMalignant Pleural Mesothelioma, Pleural Mesothelioma
Start: 2004-04-30End: 2010-07-31Updated: 2016-09-09
Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy
CompletedNCT00343720
Millennium Pharmaceuticals, Inc.Non-Small Cell Lung Cancer
Updated: 2008-03-13
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
CompletedNCT00508144
M.D. Anderson Cancer CenterLung Cancer
Start: 2005-09-30End: 2015-12-31Updated: 2017-02-13
Alimta Plus Gemcitabine for Advanced Sarcoma
CompletedNCT00860015
Columbia UniversitySarcoma, Soft Tissue
Start: 2005-08-31End: 2012-04-30Updated: 2020-08-25
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
WithdrawnNCT02662634
GU Research Network, LLCNon-small Cell Lung Cancer (NSCLC)
Start: 2016-03-31End: 2018-03-31Updated: 2022-03-18

Phase 3

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
CompletedNCT00035035
Eli Lilly and CompanyMetastases, Neoplasm, Pancreatic Neoplasms
Updated: 2006-07-19
Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
NCT01066195
Samsung Medical CenterNon-small Cell Lung Cancer
Start: 2008-05-31Target: 129Updated: 2010-02-10